semaglutide visceral fat Semaglutide-Mediated Remodeling of Adipose Tissue in Type 2 Diabetes: Molecular Mechanisms Beyond Glycemic Control Do GLP-1 Reduce Visceral Fat?
Description
It mimics the action of an incretin hormone, GLP-1 (glucagon-like peptide-1), which is naturally produced in the body after eating
A medical evaluation helps determine whether GLP-1 therapy is appropriate
Patient assistance programs: Novo Nordisks patient assistance program, NovoCare, offers free Ozempic to eligible patients with type 2 diabetes
Medication interactions and timing deserve attention
